Plasma Presepsin may Diagnose Postoperative Infections with high sensitivity and specificity
In a recent meta-analysis, Pan You and team identified a potential element in the detection of postoperative infections, that continue to plague patients undergoing various surgical procedures. The findings were published in The American Journal of Surgery.
The study encompassed data from 14 research endeavors and a pool of 1891 cases, focused on evaluating the diagnostic accuracy of presepsin, a biomarker, to detect postoperative infections. The research covered a spectrum of surgical interventions, including procedures associated with surgical site infections (SSIs), remote infections, sepsis, and septic shock.
The results brought out that, with presepsin demonstrating a sensitivity of 77% and specificity of 81%. The diagnostic odds ratio (DOR) stands at a noteworthy 14, showcasing the potential of presepsin as a reliable tool for identifying postoperative infectious complications. The area under the receiver operating characteristic curve (AUC) reached an impressive 84, underscoring the robustness of presepsin as a diagnostic marker.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.